3: Asthma Classification Flashcards
Intermittent, mild persistent, moderate persistent, or severe persistent?
Requires SABA >2 days/week but not >1/day.
Mild Persistent
What treatment step is appropriate for intermittent in all ages?
Step 1: SABA PRN
Intermittent, mild persistent, moderate persistent, or severe persistent?
Extremely limited physical activity.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Requires SABA several times/day.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Nighttime symptoms often 7 times per week (5+ age group).
Nighttime symptoms >1 times per week (0-4 age group).
Severe Persistent
What treatment step is appropriate for mild persistent in all ages?
Step 2: Low-dose ICS
Intermittent, mild persistent, moderate persistent, or severe persistent?
Nighttime symptoms 3-4 times per month (5+ age group).
Nighttime symptoms 1-2 times per month (0-4 age group).
Mild Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Exacerbations are 0-1/year.
Intermittent
Intermittent, mild persistent, moderate persistent, or severe persistent?
FEV1 >80% predicted.
- Intermittent
- Mild Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Symptoms >2 times per week but <1 time per day.
Mild Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Daily use of inhaled SABA.
Moderate Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Exacerbations affect activity, ≥2 times per week; may last days.
Moderate Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
FEV1 <60% predicted.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Asymptomatic and normal PEF between exacerbations.
Intermittent
What treatment step is appropriate for severe persistent in ages 0-4, 5-11, and 12+?
- Step 3: Medium-dose ICS and consider short-course OCS (0-11 only).
- Step 4: Medium-dose ICS + LABA and consider short-course OCS (5+ only).
- Step 5: High-dose ICS + LABA and consider short-course OCS (12+ only).
Intermittent, mild persistent, moderate persistent, or severe persistent?
Symptoms ≤2 times per week.
Intermittent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Requires SABA 2 days/week.
Intermittent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Exacerbations brief (few hours or days); varying intensity.
Intermittent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Daily symptoms.
Moderate Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Continual symptoms.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Some limitations to daily activities.
Moderate Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
All are started on long-term control medications.
Severe persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
FEV1 >60% but <80% predicted.
Moderate Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Normal FEV1 between exacerbations.
Intermittent
What treatment step is appropriate for moderate persistent in 0-11 years and 12+?
- Step 3: Medium-dose ICS and consider short-course OCS (all ages)
- Step 3: Low-dose ICS + LABA (12+ only).
Intermittent, mild persistent, moderate persistent, or severe persistent?
No interference with normal activity.
Intermittent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Exacerbations may affect activity (minor).
Mild Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Nighttime symptoms ≤2 times per month (5+ age group).
Nighttime symptoms 0 times per month (0-4 age group).
Intermittent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Frequent exacerbations.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Nighttime symptoms >1 time per week but not nightly (5+ age group).
Nighttime symptoms 3-4 times per month (0-4 age group).
Moderate Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent?
Exacerbations are 2 or more/6 months or ≥4 episodes of wheezing/year with risk factors for asthma (0-4 age group).
Exacerbations are 2 or more/year (5+ age group).
- Mild Persistent (all ages)
- Moderate Persistent (5+ age group)
- Severe Persistent (5+ age group)